Big Brother’s Rachel Reilly, Brendon Villegas Reveal Newborn’s Name

first_imgVillegas, 40, announced the birth of their son on Wednesday via Twitter. “Thank you for all the well wishes for Rachel and the baby. Rachel and our baby boy are both healthy and doing well. They are recovering at UCLA,” he wrote. “I am sure it will not be too long until Rachel shares some pics, but I will leave that up to our momma warrior. No name as of yet!”The couple — who tied the knot in September 2012 — shared the news in May that they were expecting a second child.- Advertisement – “At one point I was on oxygen and it lasted longer than my birth with Adora,” she explains. “Almost 15 hours he did not want to come out of the womb. Brendon was really supportive and my rock the whole time. He encouraged my breathing and my labor positions and helped me when I didn’t think I could keep going. He was an amazing partner and has been so helpful.”Reilly says her daughter has adjusted to having a younger sibling and has been “so helpful” and “very protective” of her little brother. The reality star admitted that she and Villegas, 40, haven’t been “sleeping at all” with a newborn under their roof, but they’ve loving every minute of it.“Our little Adler is such an amazing addition to our family. We can’t wait to get to know what his personality is going to be like,” she said, adding, “Our hearts couldn’t be more overjoyed and full.”- Advertisement – Introducing the latest addition to the Brenchel family! Rachel Reilly and Brendon Villegas exclusively revealed to Us Weekly the name of their newborn after welcoming their second child earlier this week.Reilly, 36, tells Us that her son’s name is Adler Mateo Villegas, who joins the Big Brother alums’ daughter Adora, 4. The North Carolina native— who gave birth to her infant on Wednesday, November 11 — also detailed her “super hard and scary” labor.- Advertisement – “We have a lot to celebrate this year,” Reilly wrote in a Mother’s Day Instagram post. “As a mom, it’s my day to celebrate Adora & OMG baby #2!! I can’t believe I’m pregnant!”Villegas, for his part, shared a photo of their daughter holding an ultrasound picture. “We’re having another baby and couldn’t be happier,” the California native captioned the picture.Scroll down to see photos of Reilly and Villegas’ newborn son. – Advertisement –last_img read more

South Africa pays less for ARV drugs

first_imgThe decrease in the price of various drugs ranged from 4% to 81%, resulting in a 53% reduction in the cost of the total tender, and translating to a saving of about R4.7-billion – meaning the state could now afford to treat twice as many people as previously budgeted for. South Africa’s HIV/Aids treatment programme has been given a shot in the arm, with increased competition and economies of scale enabling the government to procure R4.28-billion worth of antiretroviral drugs at less than half the cost of previous tenders. “It is notable that these tender price reductions have been achieved through the same suppliers that are contracted in the current tender,” Motsoaledi said. “There are several reasons for this, including greater efficiency in active pharmaceutical ingredient production, increased competition and a tender system that attempts to achieve the lowest possible price.” To ensure efficiency and cost-effectiveness in procurement, the last meeting of the National Health Council (NHC) of Minister and MECs approved the establishment of a Central Procurement Authority. This authority will implement measures that improve the availability and supply of medicines, achieve the lowest possible procurement prices, and ensure that suppliers are paid on time. “Given the clear evidence of the success of this approach to procurement, the Department of Health will be replicating this approach through a Central Procurement Authority,” Motsoaledi said. “The authority will focus on procurement of ARVs, TB drugs, vaccines and drugs for the treatment of diseases related to maternal and child health.” SAinfo reporterWould you like to use this article in your publication or on your website? See: Using SAinfo material 15 December 2010center_img Economies of scale Motsoaledi said the high prices had made no sense, as South Africa was the largest purchaser of ARVs in the world and should thus benefit from low prices through economies of scale. “Early this year in my health budget speech I mentioned that the prices that South Africa pays for ARVs are significantly higher than all other countries,” Health Minister Aaron Motsoaledi said in a statement this week. “The high price paid by South Africa was despite the fact that South Africa has the largest ARV programme in the world.” The drugs will support the implementation of HIV/Aids treatment in the country for the next two years, effective from 1 January 2011 to 31 December 2012. The selected suppliers include Aspen Pharma (with a 40.6% share of the tender), Sonke Pharmaceuticals (21.9%), Medpro (10.1%), Abbott Laboratories (9.8%), Cipla Medpro (5.1%), Strides Arcolab (4.2%), Adcock Ingram (4%), Aurobindo Pharma (3.1%), Specpharm (0.9%) and Merck Sharpe & Dohme (0.2%). Central procurement authoritylast_img read more